ArticlePloS one2023

Serum leucine-rich α2 glycoprotein as a potential biomarker for systemic inflammation in Parkinson's disease.

Takuma Ohmichi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.